Artia Global Partners LP Q4 2024 Filing

Filed February 14, 2025

Portfolio Value

$279.8B

Holdings

35

Report Date

Q4 2024

Filing Type

13F-HR

All Holdings (35 positions)

#StockSharesValue% PortfolioType
1
NVONOVO-NORDISK A S
450,000$38.7B13.83%Put
2
SLNOSOLENO THERAPEUTICS INC
494,424$22.2B7.94%
3
MRUSMERUS N V
463,840$19.5B6.97%
4
ITCIEURINTRA-CELLULAR THERAPIES INC
219,719$18.4B6.56%
5
ACLXARCELLX INC
229,785$17.6B6.30%
6
NUVLNUVALENT INC
204,045$16.0B5.71%
7
PCVXVAXCYTE INC
162,255$13.3B4.75%
8
ALNYALNYLAM PHARMACEUTICALS INC
56,400$13.3B4.74%
9
AZNASTRAZENECA PLC
190,752$12.5B4.47%
10
RVMDREVOLUTION MEDICINES INC
284,190$12.4B4.44%
11
VRNAVERONA PHARMA PLC
255,318$11.9B4.24%
12
IM8NINSMED INC
167,939$11.6B4.14%
13
PTGXPROTAGONIST THERAPEUTICS INC
293,851$11.3B4.05%
14
XBISPDR SER TR
100,000$9.0B3.22%Put
15
JANXJANUX THERAPEUTICS INC
162,976$8.7B3.12%
16
ARGXARGENX SE
11,311$7.0B2.49%
17
NBIXNEUROCRINE BIOSCIENCES INC
45,000$6.1B2.20%
18
VKTXVIKING THERAPEUTICS INC
90,279$3.6B1.30%
19
RYTMRHYTHM PHARMACEUTICALS INC
50,000$2.8B1.00%
20
CRNXCRINETICS PHARMACEUTICALS IN
45,765$2.3B0.84%
21
ELVNENLIVEN THERAPEUTICS INC
102,900$2.3B0.83%
22
SWTXSPRINGWORKS THERAPEUTICS INC
53,930$1.9B0.70%
23
VRDNVIRIDIAN THERAPEUTICS INC
100,000$1.9B0.69%
24
TGTXTG THERAPEUTICS INC
54,515$1.6B0.59%
25
EYPTEYEPOINT PHARMACEUTICALS INC
216,700$1.6B0.58%
26
XENEXENON PHARMACEUTICALS INC
40,000$1.6B0.56%
27
MREOMEREO BIOPHARMA GROUP PLC
421,359$1.5B0.53%
28
NAMSNEWAMSTERDAM PHARMA COMPANY
54,285$1.4B0.50%
29
CNTACENTESSA PHARMACEUTICALS PLC
80,380$1.3B0.48%
30
EWTXEDGEWISE THERAPEUTICS INC
50,000$1.3B0.48%Put
31
CRLCHARLES RIV LABS INTL INC
6,305$1.2B0.42%
32
TARSTARSUS PHARMACEUTICALS INC
20,811$1.2B0.41%
33
ASNDASCENDIS PHARMA A/S
7,440$1.0B0.37%
34
ANNXANNEXON INC
172,226$883.5M0.32%
35
TECXTECTONIC THERAPEUTIC INC
16,650$768.7M0.27%